Navigation Links
Beyond the Nobel Prize, what's next for graphene?
Date:10/13/2010

If you had never heard of "graphene" before, you might know something about it now if you've followed the 2010 Nobel Prize announcements. Two physicists at the University of Manchester (UK) were awarded the Nobel Prize in Physics "for groundbreaking experiments regarding the two-dimensional material graphene," carbon flakes that are only as thick as a single atom yet as strong as steel and as conductive as copper. But, what happens next for this revolutionary nanoscale material? Two social scientists began a study earlier in 2010 to understand the as yet undeveloped pathway to the commercialization of graphene the processes, plans, promises and perils. Team leaders with the Center for Nanotechnology in Society at Arizona State University (CNS-ASU), Jan Youtie at Georgia Institute of Technology (Georgia Tech) and Philip Shapira at the University of Manchester and Georgia Tech are in the throes of their project on the Comparative Research and Innovation Approaches of Graphene Centers.

Graphene is anticipated to have potential applications in electronics to build semiconductors beyond the limits of silicon-based technology. It also offers promising applications for higher performance solar cells, LCD screens and photon sensors. Now that graphene has been identified and found to be stable in ultra-thin sheets, research efforts to understand it more thoroughly and to produce it in large quantities have ballooned. Yet, graphene is still at the development stage, and its commercialization pathway remains to be determined.

To kick-off their work on graphene innovation, Youtie and Shapira have been undertaking field work in two of the world's leading centers for graphene development: the University of Manchester and Georgia Tech. As acknowledged by the Nobel Committee for Physics when it awarded its 2010 Prize to Manchester physicists Andre Geim and Konstantin Novoselov, Manchester is the site of seminal work on graphene, including the first laboratory production of graphene sheets. Georgia Tech is the site of a National Science Foundation-funded Materials Science and Engineering Center (MRSEC) focused on research and development on epitaxial graphene. Youtie's and Shapira's project seeks to understand similarities and differences in the plans, programs and approaches to commercialize graphene-related applications in both locations. This includes examination of both the strategies for research and development and those for fostering commercialization in terms of external partnerships in the metropolitan regions of Manchester and Atlanta, elsewhere in the country, and internationally. In addition to field work, Youtie and Shapira also are undertaking analyses of publications, patents, funding, and corporate activities in graphene.

Over the coming year, Youtie and Shapira plan to expand their research focus to other locations in the United States and around the world where graphene research and commercialization clusters are emerging. Although graphene's full impacts may take many years to materialize, the results of Youtie's and Shapira's research will provide real-time insights to researchers, companies, policymakers and other stakeholders keen to understand how research in specific nanotechnology domains moves into early applications, what barriers and concerns are raised, and how these are being addressed.


'/>"/>

Contact: Cathy Arnold
cathy.arnold@asu.edu
480-965-0555
Arizona State University
Source:Eurekalert

Related biology technology :

1. Webinar Alert: Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance
2. Beyond Turbidity: Selecting Appropriate Technology for in Situ Monitoring and Control of Complex Particle and Droplet Systems
3. Caturano and Company to Host Boston Biotech Event, "BIBA Biotech 2010 and Beyond"
4. Life Beyond Cancer Foundation Adds Bob Ingram to its Board of Directors
5. Beyond associations: Colorectal cancer culprit found
6. Informex Survey Shows Innovation Remains a Priority for 2009 and Beyond
7. Dow AgroSciences Delivering Beyond Expectations
8. Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)
9. Far From Beyond: A Glimpse into the World of Biotechnology and the Future of the Free World
10. Nobel Spotlight on IVF Boosts Family Building Procedures
11. California IVF Pioneer Donald Galen, M.D., Trained With Nobel Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. Ltd. ... KRW (US $18.9M) Series A financing. This financing round ... Tech Venture and SNU Bio Angel. This new funding ... billion KRW (US $27.7M) since its founding in 2015. ... bolster the development and commercialization of its immuno-oncology programs, ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selectorâ„¢ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
Breaking Biology Technology:
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/17/2016)... -- Global Market Watch: Primarily supported by ownership ... and Academics) market is to witness a value of US$37.1 ... highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen ... period 2014-2020. North America is not ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):